Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.33 |
| ▸ | TUBB | P07437 | 1/20 | 0.33 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.33 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.33 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.33 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.33 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.33 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.33 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.33 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.33 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.33 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.33 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.33 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12011505 | 0.94 | KDM4E (0.40) | KDM4EATML3MBTL1PIK3CDPIK3CA | |
| SCHEMBL12011507 | 0.93 | TUBB4A (0.34) | KDM4EATML3MBTL1TUBB4ATUBB | |
| SCHEMBL13669370 | 0.87 | KDM4E (0.43) | KDM4EATML3MBTL1PIK3CDPIK3CA | |
| SCHEMBL13669172 | 0.87 | KDM4E (0.43) | KDM4EATML3MBTL1PIK3CDPIK3CA | |
| SCHEMBL12571986 | 0.85 | KDM4E (0.42) | KDM4EATML3MBTL1PIK3CDPIK3CA | |
| SCHEMBL12571841 | 0.85 | KDM4E (0.42) | KDM4EATML3MBTL1PIK3CDPIK3CA | |
| SCHEMBL12571845 | 0.85 | KDM4E (0.42) | KDM4EATML3MBTL1PIK3CDPIK3CA | |
| SCHEMBL13669183 | 0.84 | KDM4E (0.43) | KDM4EATML3MBTL1PIK3CDPIK3CA | |
| SCHEMBL13432994 | 0.84 | KDM4E (0.43) | KDM4EATML3MBTL1PIK3CDPIK3CA | |
| SCHEMBL19296450 | 0.84 | KDM4E (0.43) | KDM4EATML3MBTL1PIK3CDPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8253129-B2 | Benzochrysene derivative and an organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-8253129-B2 | Benzochrysene derivative and an organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20100295029-A1 | BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. | 2010-11-25 | — | — | US | disclosed |
| US-20100295029-A1 | BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. | 2010-11-25 | — | — | US | disclosed |
| EP-2213640-A1 | BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2010-08-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100295029-A1 | BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | KSR1, NRAS, RSU1 | KDM4E 2471/4885ATM 3530/4885L3MBTL1 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.